Loading...
Biosenta Inc.
ZRO.CN•CNQ
Consumer Defensive
Household & Personal Products
CA$0.14
CA$0.005(3.70%)
Biosenta Inc. (ZRO.CN) Financial Performance & Statements
Review Biosenta Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
32.34%
↑ 32.34%
Operating Income Growth
21.54%
↑ 21.54%
Net Income Growth
64.64%
↑ 64.64%
Operating Cash Flow Growth
-41.50%
↓ 41.50%
Operating Margin
-72319.17%
↓ 72319.17%
Gross Margin
-31.58%
↓ 31.58%
Net Profit Margin
-140445.24%
↓ 140445.24%
ROE
30.35%
↑ 30.35%
ROIC
43.09%
↑ 43.09%
Biosenta Inc. (ZRO.CN) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Biosenta Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | -$199224.00 | $200252.00 | $178.00 | $173.00 |
| Cost of Revenue | $246.00 | $121.00 | $1638.00 | $95.00 |
| Gross Profit | -$199470.00 | $200131.00 | -$1460.00 | $78.00 |
| Gross Profit Ratio | $1.001 | $1.00 | -$8.20 | $0.45 |
| R&D Expenses | $9367.00 | $14210.00 | $16618.00 | $1124.00 |
| SG&A Expenses | $283424.00 | $429807.00 | $176061.00 | $252062.00 |
| Operating Expenses | $293456.00 | $444717.00 | $192679.00 | $253186.00 |
| Total Costs & Expenses | $293702.00 | $444838.00 | $194317.00 | $253280.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $314669.00 | $301755.00 | $297987.00 | $220515.00 |
| Depreciation & Amortization | $665.00 | $700.00 | $1556.00 | $247893.00 |
| EBITDA | -$398841.00 | -$244846.00 | -$195523.00 | $0.00 |
| EBITDA Ratio | $2.002 | -$1.22 | -$1081.91 | -$1463.06 |
| Operating Income | -$492926.00 | -$244586.00 | -$194140.00 | -$253110.00 |
| Operating Income Ratio | $2.47 | -$1.22 | -$1090.67 | -$1463.06 |
| Other Income/Expenses (Net) | -$221249.00 | -$302710.00 | -$300929.00 | -$218031.00 |
| Income Before Tax | -$714175.00 | -$547296.00 | -$495068.00 | -$471139.00 |
| Income Before Tax Ratio | $3.58 | -$2.73 | -$2781.28 | -$2723.35 |
| Income Tax Expense | $0.00 | $0.00 | $4.00 | -$247893.00 |
| Net Income | -$714175.00 | -$547296.00 | -$495068.00 | -$471139.00 |
| Net Income Ratio | $3.58 | -$2.73 | -$2781.28 | -$2723.35 |
| EPS | -$0.02 | -$0.02 | -$0.02 | -$0.02 |
| Diluted EPS | -$0.02 | -$0.02 | -$0.02 | -$0.02 |
| Weighted Avg Shares Outstanding | $28.78M | $28.78M | $27.48M | $26.46M |
| Weighted Avg Shares Outstanding (Diluted) | $28.78M | $28.78M | $27.48M | $26.46M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan